Dali-on, Pablo G.
HRN: 22-25-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
CIPROFLOXACIN 500MG (TAB)
11/29/2022
12/06/2022
PO
500mg
BID
Infectious Diarrhea, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes